Arisido, Maeregu Woldeyes
Foco, Luisa
Shoemaker, Robin
Melotti, Roberto
Delles, Christian
Gögele, Martin
Barolo, Stefano
Baron, Stephanie
Azizi, Michel
Dominiczak, Anna F.
Zennaro, Maria-Christina
P. Pramstaller, Peter
Poglitsch, Marko
Pattaro, Cristian
Article History
Received: 20 January 2023
Accepted: 23 April 2023
First Online: 27 May 2023
Declarations
:
: The CHRIS study was approved by the Ethical Committee of the Healthcare System of the Autonomous Province of Bozen/Bolzano, protocol no. 21/2011 (19 Apr 2011). All participants gave written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Marko Poglitsch is the CEO of Attoquant diagnostics that performed the biomarker measurements.